RNS Number : 0995R
Induction Healthcare Group PLC
04 March 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Change of Adviser
Appointment of N+1 Singer as Nominated Adviser & Sole Broker
Induction Healthcare (AIM: INHC), a leading healthcare technology company that helps to digitally transform hospitals, announces the appointment of N+1 Singer as Nominated Adviser and Sole Broker with immediate effect.
ENQUIRIES
Induction Healthcare
https://inductionhealthcare.com
Dr Hugo Stephenson, Joint Chief Executive Officer
Via Walbrook PR
James Balmain, Joint Chief Executive Officer
N+1 Singer (Nominated Adviser and Broker)
+44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd
+44 (0)20 7933 8780 or induction@walbrookpr.com
Paul McManus / Alice Woodings
+44 (0)7980 541 893 / +44 (0)7407 804 654
About Induction Healthcare - https://inductionhealthcare.com
Induction Healthcare (AIM: INHC) is a UK-based leading healthcare technology company enabling the digital transformation of hospitals. We make a range of time-saving tools that work with existing hospital IT systems, benefitting staff and patients, while ensuring the highest standards of clinical safety and information security.
More than 190,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 150,000 patients, choose Induction platforms.
Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.
Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.
Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPDZGGFLFNGMZM
